Caribou Biosciences, Inc. (CRBU) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $0.42 (-5.04%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 4, 2025 | Asthika Goonewardene | Truist Financial | $7.00 | +1556.6% |
| Jun 3, 2024 | Liisa Bayko | Evercore ISI | $3.00 | +610.0% |
Top Analysts Covering CRBU
CRBU vs Sector & Market
| Metric | CRBU | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.67 | 2.25 | 2.41 |
| Analyst Count | 6 | 8 | 19 |
| Target Upside | +136.7% | +153002.0% | +21.5% |
| P/E Ratio | -1.33 | 3.47 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $19M | $19M | $19M | 2 |
| 2027-12-31 | $6M | $25M | $43M | 4 |
| 2028-12-31 | $9M | $27M | $74M | 5 |
| 2029-12-31 | $23M | $74M | $199M | 2 |
| 2030-12-31 | $51M | $164M | $444M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.22 | $-0.22 | $-0.22 | 1 |
| 2027-12-31 | $-1.35 | $-1.30 | $-1.24 | 3 |
| 2028-12-31 | $-1.91 | $-1.51 | $-1.15 | 5 |
| 2029-12-31 | $-5.57 | $-1.74 | $-0.19 | 1 |
| 2030-12-31 | $-5.89 | $-1.84 | $-0.20 | 1 |
Frequently Asked Questions
What is the analyst consensus for CRBU?
The consensus among 6 analysts covering Caribou Biosciences, Inc. (CRBU) is Hold with an average price target of $5.00.
What is the highest price target for CRBU?
The highest price target for CRBU is $7.00, set by Asthika Goonewardene at Truist Financial on 2025-11-04.
What is the lowest price target for CRBU?
The lowest price target for CRBU is $3.00, set by Liisa Bayko at Evercore ISI on 2024-06-03.
How many analysts cover CRBU?
6 analysts have issued ratings for Caribou Biosciences, Inc. in the past 12 months.
Is CRBU a buy or sell right now?
Based on 6 analyst ratings, CRBU has a consensus rating of Hold (2.67/5) with a +136.7% upside to the consensus target of $5.00.
What are the earnings estimates for CRBU?
Analysts estimate CRBU will report EPS of $-0.22 for the period ending 2026-12-31, with revenue estimated at $19M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.